Skip to main content
Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
90.90
-2.11 (-2.27%)
At close: Mar 6, 2026, 4:00 PM EST
90.45
-0.45 (-0.50%)
After-hours: Mar 6, 2026, 7:57 PM EST

Medtronic Revenue by Segment
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Cardiovascular
13.51B 13.09B 12.76B 12.48B 12.28B 12.17B 11.99B 11.83B
Cardiovascular Growth
10.08% 7.61% 6.43% 5.49% 2.27% 2.71% 2.50% 2.35%
Neuroscience
10.16B 10.06B 9.95B 9.85B 9.77B 9.67B 9.51B 9.41B
Neuroscience Growth
3.94% 4.01% 4.63% 4.67% 5.38% 5.49% 4.88% 5.00%
Medical Surgery
8.64B 8.54B 8.50B 8.41B 8.39B 8.47B 8.48B 8.53B
Medical Surgery Growth
2.92% 0.80% 0.13% -1.40% -0.70% 0.33% 1.36% 2.34%
Diabetes
3.00B 2.90B 2.83B 2.76B 2.69B 2.63B 2.56B 2.49B
Diabetes Growth
11.72% 10.14% 10.64% 10.73% 10.90% 11.90% 11.22% 9.99%
Other
171.00M 171.00M 173.00M 48.00M 74.00M 59.00M 44.00M 112.00M - - - - - - - - - - - - -
Other Growth
131.08% 189.83% 293.18% -57.14% - - - - - - - - - - - - - - - - -

Revenue by Geography
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
United States
17.78B 17.52B 17.31B 17.17B 16.97B 16.85B 16.72B 16.56B
United States Growth
4.80% 4.01% 3.54% 3.67% 1.62% 1.27% 1.14% 1.15%
Rest of World
17.70B 17.23B 16.89B 16.37B 16.23B 16.15B 15.86B 15.80B
Rest of World Growth
9.06% 6.74% 6.51% 3.58% 3.90% 5.40% 5.52% 6.38%

Operating Expense Breakdown
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022
Selling, General, and Administrative
11.45B 11.21B 11.00B 10.85B 10.89B 10.85B 10.78B 10.74B
Selling, General, and Administrative Growth
5.09% 3.31% 2.06% 1.05% 2.89% 3.04% 3.04% 3.09%
Research and Development
2.89B 2.84B 2.78B 2.73B 2.72B 2.74B 2.74B 2.74B
Research and Development Growth
5.99% 3.50% 1.38% -0.15% 0.81% 1.82% 2.69% 1.48%
Amortization
1.93B 1.90B 1.85B 1.81B 1.66B 1.67B 1.68B 1.69B
Amortization Growth
15.94% 14.23% 10.44% 6.80% -2.00% -2.52% -1.58% -0.35%
Litigation
325.00M - 344.00M 361.00M 212.00M - 230.00M 119.00M - 110.00M 79.00M - - - -
Litigation Growth
41.30% - 189.08% 228.18% 168.35% - 253.85% - - - - - - - -
Restructuring
279.00M 245.00M 265.00M 267.00M 232.00M 209.00M 219.00M 226.00M
Restructuring Growth
20.26% 17.22% 21.00% 18.14% -43.14% -50.94% -47.36% -39.89%
Other Expenses
142.00M 102.00M 46.00M -23.00M 439.00M 461.00M 464.00M 464.00M
Other Expenses Growth
-67.65% -77.87% -90.09% - 920.93% - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.